Clinical Trial Update: Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on convalescent plasma therapy for COVID-19 patients with acute respiratory distress syndrome across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Convalescent plasma therapy

Snippet

Sponsor: Indonesia University | Conditions: COVID, Acute Respiratory Distress Syndrome | Phase 2, Phase 3 | Status: UNKNOWN